Jaime Xinos
Known title: Chief Commercial OfficerCIK: 0002041627
Associated companies
Transaction History
| ACHV | ▲ Buy | Option Exercise | 69,000 | $0 | 9/4/2025 | View on chart |
| ACHV | ▼ Sell | Open Market | 20,854 | $58K | 9/4/2025 | View on chart |
| ACHV | ▲ Buy | Option Exercise | 69,000 | $0 | 9/4/2025 | View on chart |
| ACHV | ▼ Sell | Open Market | 20,854 | $58K | 9/4/2025 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Lisata Therapeutics adds Jeffrey Farrow to board
Lisata Therapeutics, the parent company of Achieve Life Sciences, has appointed Jeffrey Farrow to its board of directors. Farrow is a veteran in biopharma finance, bringing experience in capital markets and corporate strategy. This move signals a focus on strengthening the company's financial leadership and governance structure as it navigates its current market position.
Lisata Therapeutics adds Jeffrey Farrow to board. Lisata Therapeutics, the parent company of Achieve Life Sciences, has appointed Jeffrey Farrow to its board of directors. Farrow is a veteran in biopharma finance, bringing experience in capital markets and corporate strategy. This move signals a focus on strengthening the company's financial leadership and governance structure as it navigates its current market position.